Monday, October 26, 2026 · Daily editionET --:--:--

Finished

In Vivo Measurement of the Accuracy of the "Neurolocate" Module of the Neurosurgical Robot "Neuromate" in Its Application to Deep Brain Stimulation

NCT04712552 · Centre Hospitalier Universitaire de Nice · Updated 24 March 2026

What is being tested
deep brain stimulation
For
Parkinson Disease; Dystonia; Tremor
Kind of study
Watches patients without assigning a treatment. No drug phase (a device or procedure study).
Who can join
Ages 18 years to 70 years. About 18 people. The full rules are on the registry page.
Where
France
When
Starts or started 26 Jan 2021, ends 7 Jan 2023. Registered 15 Jan 2021.
Results
None posted yet.

In the researchers' words

The purpose of this study is to evaluate the accuracy of the Neurolocate recording system of the neurosurgical robot Neuromate, marketed by Renishaw, in order to optimize surgical procedures, costs and patient comfort.
ClinicalTrials.gov, NCT04712552

Sites

  • Department of neurosurgeryNice, France